Projects per year
Search results
-
Active
-
A Phase 2/3, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Oral Ozanimod (RPC1063) in Pediatric Participants with Moderately to Severely Active Crohn’s Disease with an Inadequate Response to Conventional Therapy
20/05/24 → 19/05/29
Project: Research
-
A Phase 2/3, Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Oral Ozanimod (RPC1063) in Pediatric Subjects with Moderately to Severely Active Ulcerative Colitis with an Inadequate Response to Conventional Therapy
22/01/24 → 21/01/29
Project: Research
-
PROPHECY: Profiling immune RespOnses in Paediatric and High risk populations to SARS-CoV-2
McMahon, J., van Zelm, M., Khoury, G., Drummer, H., Mulley, W., Holland, A., Woolley, I., Ojaimi, S., Rogers, B., Hoi, A., Trauer, J., Sparrow, M., Licciardi, P. V., Giles, E., Curtis, D., Crawford, N., Leech, M., Westall, G., O'Hehir, R., Jones, A., Morand, E., Bosco, J. J. & Turner, S.
Monash University, Alfred Health, Monash Health, Murdoch Children's Research Institute, Burnet Institute (Australia), Spleen Australia, National Association of People with HIV Australia (NAPWHA) Incorporated, Musculoskeletal Australia , Safer Care Victoria (SCV)
1/06/22 → 30/05/26
Project: Research
-
Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects with Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open–Label Vedolizumab Intravenous Therapy
4/11/21 → 7/10/26
Project: Research